Heart Transplant Program

This is a golden age of heart transplantation, and the Heart Transplant Program at the Smidt Heart Institute is a trailblazer for the procedure in the United States and around the world.

For four years in a row, the program has completed more adult heart transplants than any other medical facility in the nation. Heart failure—when he heart pumps less blood than the body needs—is the most common reason for the procedure.

Led by Jon Kobashigawa, MD, our expert team offers the most sophisticated options available in cardiac support devices, surgical techniques and anti-rejection technologies. Our responsive staff provides patients with financial and psychosocial support to ease the transition to a donor heart.

From 2010 through 2014, our comprehensive approach to care led to 91 percent of our patients living more than a year after their heart transplant. That surpassed the projected survival rate determined by the United Network for Organ Sharing (UNOS).

Our physicians work closely with other programs, including the Heart Failure Program, Mechanical Circulatory Support Program, Interventional Cardiology and the Regenerative Medicine Clinic.

More than a thousand patients have undergone transplants at Cedars-Sinai since the Heart Transplant Program was established in 1988, according to UNOS. Because we treat more of these patients than any other center in the United States, we can tailor our approach to each individual's needs.

Heart drug
Anti-Antibody Solution May Reduce Rejection After Transplant

The Cedars-Sinai Heart Transplant Program is testing a new medication that could help patients whose bodies are likely to reject a donor organ. The drug blunts the ability of antibodies to destroy the new heart.

DNA Stock Image
Blood Test Detects Heart Rejection

Cedars-Sinai researchers study a new blood test capable of detecting donor DNA in transplant recipient's blood stream.

Cardiac Amyloidosis

Our cardiologists offer options for patients with cardiac amyloidosis, a rare disorder that, left untreated, can lead to advanced heart failure.

Program Director

Jon A. Kobashigawa, MD

"The opportunity to be part of this process is a gift."